Sangamo Therapeutics Raises $250 Million in Stock Offering Amidst Price Drop

Sangamo Therapeutics has priced a $250 million underwritten offering, selling 35.2 million shares of common stock and 17.8 million pre-funded warrants. The combined offering price is $0.4719 per share. The net proceeds will support operations, advance clinical development programs, and general corporate purposes. The stock price has plunged 28% to $0.40.